Announcements Trials
Browse Landscape

Phase

Phase 1 10Phase 1/2 6Phase 2/3 1Phase 2 1

Status

Terminated 2Unknown 1Suspended 1Recruiting 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 6

Sponsor

Cancer Type

CNS 3Gastrointestinal 2Tumor-Agnostic 1

Conditions

Glioma 2Glioblastoma 2Colorectal Neoplasms 2Neoplasms 1Digestive System Neoplasms 1Brain Neoplasms 1

Interventions

pembrolizumab 410Cyclophosphamide 394Carboplatin 306Gemcitabine 286Nivolumab 276Paclitaxel 274Cisplatin 252Radiotherapy 225Dexamethasone 210Bevacizumab 209fludarabine 192Docetaxel 187Rituximab 183Capecitabine 171Oxaliplatin 158Lenalidomide 157Fluorouracil 152Temozolomide 138Cytarabine 135Etoposide 128Irinotecan 124Cetuximab 123fludarabine phosphate 120Injections 118venetoclax 116Ipilimumab 115Doxorubicin 114Azacitidine 108130-nm albumin-bound paclitaxel 108Pemetrexed 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 1/2 × Flucytosine × Clear all
NCT06504381 2026-03-11

DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma

University of California, San Francisco

Phase 1/2 Recruiting
70 enrolled
CNS

Glioma

NCT06562621 2024-08-20

Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma

Beijing Neurosurgical Institute

Phase 1/2 Completed
38 enrolled
CNS

Glioblastoma, Glioma

NCT03724071 2023-06-23

Study of TG6002 (VV TK-RR-FCU1) in Combination With 5-FC in Patients With Advanced Gastro-intestinal Tumors.

Transgene

Phase 1/2 Terminated
51 enrolled
Gastrointestinal

Digestive System Neoplasms, Colorectal Neoplasms

NCT04194034 2023-06-23

Study of Intrahepatic Arterial Infusion of TG6002 in Combination With 5-FC in Patients With Metastatic Colorectal Cancer

Transgene

Phase 1/2 Terminated
15 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01562626 2021-05-12

Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors

Anaeropharma Science, Inc.

Phase 1/2 Suspended
75 enrolled
Tumor-Agnostic

Neoplasms

NCT03294486 2017-11-06

ONCOVIRAC

Assistance Publique - Hôpitaux de Paris

Phase 1/2 Unknown
78 enrolled
CNS

Brain Neoplasms, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡